These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1383888)

  • 1. Regional cerebral protein synthesis after transient ischemia in the rat: effect of the AMPA antagonist NBQX.
    Frank L; Bruhn T; Diemer NH
    Neurosci Lett; 1992 Jun; 140(1):108-12. PubMed ID: 1383888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of an AMPA antagonist (NBQX) on postischemic neuron loss and protein synthesis in the rat brain.
    Frank L; Bruhn T; Diemer NH
    Exp Brain Res; 1993; 95(1):70-6. PubMed ID: 7691645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AMPA antagonist, NBQX, protects against ischemia-induced loss of cerebellar Purkinje cells.
    Balchen T; Diemer NH
    Neuroreport; 1992 Sep; 3(9):785-8. PubMed ID: 1384770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P; Diemer NH; Bruhn T; Johansen FF
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of NMDA and AMPA receptor blockade on protein synthesis in the rat infarct borderzone.
    Christensen T; Bruhn T; Frank L; Diemer NH
    Acta Neurol Scand; 1996; 93(2-3):160-7. PubMed ID: 8741137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against post-ischemic behavioral pathology by the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil.
    Judge ME; Sheardown MJ; Jacobsen P; Honoré T
    Neurosci Lett; 1991 Dec; 133(2):291-4. PubMed ID: 1667818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.
    Sheardown MJ; Nielsen EO; Hansen AJ; Jacobsen P; Honoré T
    Science; 1990 Feb; 247(4942):571-4. PubMed ID: 2154034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.
    Sheardown MJ; Suzdak PD; Nordholm L
    Eur J Pharmacol; 1993 Jun; 236(3):347-53. PubMed ID: 7689464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA and non-NMDA receptor gene expression following global brain ischemia in rats: effect of NMDA and non-NMDA receptor antagonists.
    Pellegrini-Giampietro DE; Pulsinelli WA; Zukin RS
    J Neurochem; 1994 Mar; 62(3):1067-73. PubMed ID: 8113793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NBQX inhibits AMPA-induced locomotion after injection into the nucleus accumbens.
    Boldry RC; Kelland MD; Engber TM; Chase TN
    Brain Res; 1993 Jan; 600(2):331-4. PubMed ID: 7679606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury.
    Li H; Buchan AM
    J Cereb Blood Flow Metab; 1993 Nov; 13(6):933-9. PubMed ID: 7691852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against ischemic hippocampal CA1 damage in the rat with a new non-NMDA antagonist, NBQX.
    Diemer NH; Jørgensen MB; Johansen FF; Sheardown M; Honoré T
    Acta Neurol Scand; 1992 Jul; 86(1):45-9. PubMed ID: 1325729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Turski L; Jacobsen P; Honoré T; Stephens DN
    J Pharmacol Exp Ther; 1992 Feb; 260(2):742-7. PubMed ID: 1371159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats.
    Wachtel H; Kunow M; Löschmann PA
    Neurosci Lett; 1992 Aug; 142(2):179-82. PubMed ID: 1280793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroprotective and hypothermic effect of GYKI-52466, a non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model.
    Gyertyán I; Gigler G; Simó A
    Brain Res Bull; 1999 Oct; 50(3):179-86. PubMed ID: 10566979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline) did not affect recovery of high energy phosphates and pH in early reperfusion in a rat model of transient forebrain ischemia. Or: an in vivo 31P NMR spectroscopy study.
    Müller TB; Haraldseth O; Sonnewald U; Unsgård G; Petersen SB
    Acta Anaesthesiol Scand; 1994 Feb; 38(2):170-4. PubMed ID: 8171953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution.
    Randle JC; Guet T; Cordi A; Lepagnol JM
    Eur J Pharmacol; 1992 May; 215(2-3):237-44. PubMed ID: 1382998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro.
    Zeman S; Lodge D
    Br J Pharmacol; 1992 Jun; 106(2):367-72. PubMed ID: 1382781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.